The Latest Breaking News from CPRIT

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit

CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE: UNH).

Benzinga · Sep 25, 2025

Could Texas do for Alzheimer’s research what it did for cancer?

Modeled after the state’s $6 billion cancer research fund, the dementia fund — a legislative priority for Lt. Gov. Dan Patrick — could pump hundreds of millions of dollars into Texas researchers.

The Texas Tribune · Nov 21, 2024